LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
12,206,146
Share change
-667,627
Total reported value
$12,918,000
Price per share
$1.05
Number of holders
16
Value change
-$889,192
Number of buys
2
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q1 2016

As of 31 Mar 2016, LOMBARD MED INC - COM (EVAR) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,206,146 shares. The largest 10 holders included Invesco Ltd., Abingworth LLP, SV Life Sciences Advisers, LLC, Aisling Capital LLC, CITADEL ADVISORS LLC, DEUTSCHE BANK AG\, Weiss Multi-Strategy Advisers LLC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, and Texas Yale Capital Corp.. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.